These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 35680489)
1. Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. Barale M; Massano M; Bioletto F; Maiorino F; Pusterla A; Mazzetti R; Trentini L; Bonora S; Di Perri G; Ghigo E; Procopio M Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1936-1943. PubMed ID: 35680489 [TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance. Freitas P; Carvalho D; Santos AC; Mesquita J; Matos MJ; Madureira AJ; Martinez E; Sarmento A; Medina JL BMC Infect Dis; 2012 Aug; 12():180. PubMed ID: 22866963 [TBL] [Abstract][Full Text] [Related]
3. Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome. Freitas P; Carvalho D; Santos AC; Madureira AJ; Martinez E; Pereira J; Sarmento A; Medina JL BMC Infect Dis; 2014 Jun; 14():347. PubMed ID: 24958357 [TBL] [Abstract][Full Text] [Related]
4. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. Bonnet E; Delpierre C; Sommet A; Marion-Latard F; Hervé R; Aquilina C; Labau E; Obadia M; Marchou B; Massip P; Perret B; Bernard J J Clin Densitom; 2005; 8(3):287-92. PubMed ID: 16055958 [TBL] [Abstract][Full Text] [Related]
5. Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals. Beraldo RA; Vassimon HS; Aragon DC; Navarro AM; Albuquerque de Paula FJ; Foss-Freitas MC Eur J Clin Nutr; 2015 Feb; 69(2):274-8. PubMed ID: 25074393 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study. Jumare J; Dakum P; Sam-Agudu N; Memiah P; Nowak R; Bada F; Oguama U; Odonye G; Adebiyi R; Cairo C; Kwaghe V; Adebamowo C; Abimiku A; Charurat M BMC Endocr Disord; 2023 Jul; 23(1):160. PubMed ID: 37507703 [TBL] [Abstract][Full Text] [Related]
7. Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients. Domingo P; Lamarca MK; Gallego-Escuredo JM; Torres F; Domingo JC; Villarroya J; Gutierrez Mdel M; Mateo MG; Vidal F; Villarroya F; Giralt M J Antimicrob Chemother; 2015; 70(6):1825-32. PubMed ID: 25700720 [TBL] [Abstract][Full Text] [Related]
8. Correlation between fat-to-muscle mass ratio and cognitive impairment in elderly patients with type 2 diabetes mellitus: a cross-sectional study. Wu F; Liu Y; Lin C; Haghbin N; Xia L; Li Y; Chen T; Qiu H; Jiang W; Li J; Lin J BMC Geriatr; 2024 Apr; 24(1):352. PubMed ID: 38637745 [TBL] [Abstract][Full Text] [Related]
9. Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy. Freitas P; Santos AC; Carvalho D; Pereira J; Marques R; Martinez E; Sarmento A; Medina JL J Clin Densitom; 2010; 13(2):197-203. PubMed ID: 20347364 [TBL] [Abstract][Full Text] [Related]
10. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. Seo YG; Song HJ; Song YR J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):710-725. PubMed ID: 32030917 [TBL] [Abstract][Full Text] [Related]
11. Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents. Bicudo Bruno Nogueira A; Abreu JM; Mesquita Villela M; Boracini Sanchez AE; Silva Chaves B; Setubal S; Coca Velarde LG; Cruz Filho RAD; Balarini Lima GA; Soares DV J Clin Densitom; 2020; 23(4):623-629. PubMed ID: 30545683 [TBL] [Abstract][Full Text] [Related]
12. Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients. Freitas P; Carvalho D; Santos AC; Madureira AJ; Xerinda S; Martinez E; Pereira J; Sarmento A; Medina JL J Clin Hypertens (Greenwich); 2012 Sep; 14(9):593-600. PubMed ID: 22947357 [TBL] [Abstract][Full Text] [Related]
13. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren. Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095 [TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-associated lipodystrophy: an objective definition based on dual-energy x-ray absorptiometry-derived regional fat ratios in a South Asian population. Asha HS; Seshadri MS; Paul TV; Abraham OC; Rupali P; Thomas N Endocr Pract; 2012; 18(2):158-69. PubMed ID: 21856599 [TBL] [Abstract][Full Text] [Related]
15. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783 [TBL] [Abstract][Full Text] [Related]
16. Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study. Domingo P; Gutierrez Mdel M; Gallego-Escuredo JM; Torres F; Mateo GM; Villarroya J; de los Santos I; Domingo JC; Villarroya F; Del Rio L; Estrada V; Giralt M PLoS One; 2014; 9(2):e89088. PubMed ID: 24586518 [TBL] [Abstract][Full Text] [Related]
17. Relationship Between Adiposity Indices, Lipodystrophy, and Sarcopenia in HIV-Positive Individuals With and Without Lipodystrophy. Mialich MS; Dos Santos AP; da Silva BR; de Paula FJ; Jordão AA; Navarro AM J Clin Densitom; 2017; 20(1):73-81. PubMed ID: 27439325 [TBL] [Abstract][Full Text] [Related]
18. Association of Muscular Fitness and Body Fatness with Cardiometabolic Risk Factors: The FUPRECOL Study. Correa-Rodríguez M; Ramírez-Vélez R; Correa-Bautista JE; Castellanos-Vega RDP; Arias-Coronel F; González-Ruíz K; Alejandro Carrillo H; Schmidt-RioValle J; González-Jiménez E Nutrients; 2018 Nov; 10(11):. PubMed ID: 30424569 [TBL] [Abstract][Full Text] [Related]
19. Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function. Andersen O; Haugaard SB; Andersen UB; Friis-Møller N; Storgaard H; Vølund A; Nielsen JO; Iversen J; Madsbad S Metabolism; 2003 Oct; 52(10):1343-53. PubMed ID: 14564688 [TBL] [Abstract][Full Text] [Related]
20. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study. Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]